Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by consultant99on Apr 29, 2022 10:37am
303 Views
Post# 34642201

RE:RE:RE:RE:RE:RE:It looks like---

RE:RE:RE:RE:RE:RE:It looks like---

If all the other warrant holders followed a similar pattern then the company lost the opportunity to raise some cash and it begs the question as to how and why the share price fell like a stone after the PR.

One of the reasons I dislike financing using privately issued warrants is the potential for using the warrants as a hedge; they only have value when you use them..

From the looks of the share price TLT is definitely oversold but the gap fill at 0.245 seems the short term downside target. The publically traded warrants have been falling faster than the share price and I am using this opportunity to sell my remaining shares and buy warrants to replace them. It's a gutty move if there are more unexpected delays but gives me maximum leverage to the upside. 

When the share price was in the high 0.40s the ratio of warrants to stock was around 1.6:1 whereas I was able to do a recent swap at closer to 2:1 

I think when the warrant price starts to firm it will be another indicator that the stock has bottomed and higher prices are on the way.

<< Previous
Bullboard Posts
Next >>